Pilot study suggests senolytic medications may boost cognition in Alzheimer's risk group
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that ...
Researchers identify potential link between retinal changes, Alzheimer's disease
A team of scientists at the Indiana University School of Medicine has identified that an eye condition affecting the retina, ...
manilatimes13h
Cognition Therapeutics Successfully Passes Pre-defined Futility Analysis of Phase 2 Study of Oral Zervimesine (CT1812) in Geographic Atrophy
To date, the MAGNIFY study ( NCT05893537) has enrolled 100 participants. All participants are completing a final clinic visit in February 2025. Cognition intends to unblind the study at the end of ...
New Atlas22h
Pair of common viruses may trigger Alzheimer’s disease
A fascinating collaborative study in 2022, between researchers at the University of Oxford and Tufts University, suggested ...